Cancer, Advanced Active Not Recruiting Phase 1 Trials for Paclitaxel (DB01229)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03307785Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042Treatment
NCT01187199Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced CancerTreatment
NCT01113476Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesTreatment
NCT01015222Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced MalignanciesTreatment